Annals of Saudi Medicine (May 2012)

A fatal case of cutaneous adverse drug-induced toxic epidermal necrolysis associated with severe rhabdomyolysis

  • Sheik Oaleed Noordally,
  • Schoeb Sohawon,
  • Julien Vanderhulst,
  • Ruth Duttmann,
  • Francis Corazza,
  • Jacques Devriendt

DOI
https://doi.org/10.5144/0256-4947.2012.309
Journal volume & issue
Vol. 32, no. 3
pp. 309 – 311

Abstract

Read online

Toxic epidermal necrolysis represents an immunologic reaction to a foreign antigen and is most often caused by drugs. Atorvastatin, a blood cholesterol–lowering agent, is a recognized cause of rhabdomyolysis; while naproxen, a widely used nonsteroidal anti-inflammatory drug, is a known cause of photo-induced skin lesions. We report the first fatal case of drug-induced toxic epidermal necrolysis associated with severe muscle necrosis due to the use of a nonsteroidal anti-inflammatory drug and a statin with very high levels of creatine phosphokinase leading to acute kidney injury, disseminated intravascular coagulation, and complete skin necrosis leading to death.